Journal of Sleep Research, 2020 Association between proteomics and obstructive sleep apnea phenotypes in a community‐based cohort of women Ljunggren M., Theorell‐Haglöw J., Freyhult E. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Genome Medicine, 2020 Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy Reustle A., Di Marco M., Meyerhoff C. et al. Olink Target 96OncologyImmunotherapyPatient StratificationTissue Lysate | | | | |
Cytokine, 2020 Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection assay Taslimi Y., Agbajogu C., Brynjolfsson S. et al. Olink Target 96Infectious DiseasesTechnical EvaluationTape Disc Supernatant | | | | |
The Lancet Rheumatology, 2020 Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial van der Heijden E., Blokland S., Hillen M. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
Journal of the American Heart Association, 2020 PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle‐Aged Population: The STANISLAS Cohort Ferreira J., Xhaard C., Lamiral Z. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Cells, 2020 Pro-Inflammatory Priming of Umbilical Cord Mesenchymal Stromal Cells Alters the Protein Cargo of Their Extracellular Vesicles Hyland M., Mennan C., Wilson E. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyEV Lysate | | | | |
Arteriosclerosis, Thrombosis, and Vascular Biology, 2020 Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1 Garshick M., Tawil M., Barrett T. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma | | | | |
European Journal of Heart Failure, 2020 Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls Tromp J., Boerman L., Sama I. et al. Olink Target 96OncologyCVDPathophysiologyPlasma | | | | |
Lupus, 2020 Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammation Carranza-León D., Oeser A., Marton A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2020 Differential Expression of Circulating Inflammatory Proteins Following Sport-Related Traumatic Brain Injury Begum G., Reddy R., Yakoub K. et al. Olink Target 96NeurologyPatient StratificationSerum | | | | |
Nature Communications, 2020 Neurology-related protein biomarkers are associated with cognitive ability and brain volume in older age Harris S., Cox S., Bell S. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Cerebrovascular Diseases Extra, 2020 Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study Tancin Lambert A., Kong X., Ratajczak-Tretel B. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Journal of Neurotrauma, 2020 Alterations in Plasma microRNA and Protein Levels in War Veterans with Chronic Mild Traumatic Brain Injury Ghai V., Fallen S., Baxter D. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
JACC: Heart Failure, 2020 Distinct Pathological Pathways in Patients With Heart Failure and Diabetes Tromp J., Voors A., Sharma A. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Clinical Research in Cardiology, 2020 Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study Lombardi C., Ferreira J., Carubelli V. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Leukemia Research, 2020 Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy Söderlund S., Persson I., Ilander M. et al. Olink Target 96OncologyPathophysiologyPatient StratificationPlasma | | | | |
Heart and Vessels, 2020 Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics Ahmed S., Ahmed A., Säleby J. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Atherosclerosis, 2020 The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: A meta-analysis and a longitudinal evaluation Lind L., Gigante B., Borne Y. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
ESC Heart Failure, 2020 Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial Ferreira J., Duarte K., Woehrle H. et al. CVDPatient Stratification | | | | |
Journal of Diabetes Research, 2020 Association of Glycated Proteins with Inflammatory Proteins and Periodontal Disease Parameters Panezai J., Altamash M., Engstrӧm P. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |